Post-effective amendment to a registration statement that is not immediately effective upon filing

Condensed Consolidated Statements Of Cash Flows

v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended 12 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Cash flows from operating activities:          
Net loss $ (12,305) $ (2,535) $ (6,834) $ (5,886) $ (25,434)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization 26 69 85 169 213
Amortization of loan discount 1,272 22 132    
Stock-based compensation 808 336 733 1,523 1,907
Non-cash gain on changes in fair value of stock warrants (760)        
Gain on investments       (9) (120)
Changes in operating assets and liabilities:          
Receivables (1,572) (1,838) (1,159)    
Prepaid expenses and other assets (605) 69 (44) 405 (281)
Accounts payable and other accrued liabilities 848 2,170      
Accounts payables     2,122 (158) (64)
Accrued clinical trials and other liabilities     308 (1,454) (1,558)
Net cash used in operating activities (12,288) (1,707) (4,657) (5,407) (25,337)
Gain on disposition of property and equipment       3  
Cash flows from investing activities:          
Purchases of furniture and equipment (58) (20) (28) (7) (100)
Proceeds from the sales of investments       9 120
Proceeds from sale of marketable securities         4,401
Disposals of furniture and equipment 2        
Net cash used in investing activities (56) (20) (28) 2 4,421
Cash flows from financing activities:          
Proceeds from long-term debt, net 19,500 5,000 5,000 3,000  
Proceeds from issuance of common stock from private placement       478 (26)
Proceeds from issuance of common stock from exercise of stock options       555  
Payments on long-term debt (7,564) (172) (435)    
Net cash provided by financing activities 11,936 4,828 4,565 4,033 (26)
Net (decrease) increase in cash and cash equivalents (408) 3,101 (120) (1,372) (20,942)
Cash and cash equivalents at beginning of period 3,180 3,300 3,300 4,672 25,614
Cash and cash equivalents at end of period 2,772 6,401 3,180 3,300 4,672
Interest Paid     678 9  
Retirement of preferred stock upon dissolution     $ 1,241